PS treatment decreased the p-AKT levels in MCF-7 breast cancer cells, suggesting that the PI3K/AKT pathway suppressed the Wnt/β-catenin pathway in breast cancer [54]. The gene discussed is AKT1; the disease is breast carcinoma.